| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |